NCT03297788View on ClinicalTrials.gov

Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

October 1, 2023

Study Completion Date

December 1, 2023

Conditions
SCLCBrain Metastases
Interventions
RADIATION

SRS

"For SRS the dose prescription to the PTV will be as follows:~* 20 Gy to the 70%-isodose (lesions \< 2 cm max. diameter)~* 18 Gy to the 70%-isodose (lesions 2 - 3 cm max. diameter)~* 6 x 5 Gy to the conformally surrounding isodose (lesions \> 3 cm max. diameter)"

RADIATION

WBRT

WBRT will be applied in 10 fractions with single doses of 3 Gy to the whole brain.

Trial Locations (1)

69120

University Hospital of Heidelberg, Department of Radiation Oncology, Heidelberg

All Listed Sponsors
collaborator

Heidelberg University

OTHER

lead

Juergen Debus

OTHER

NCT03297788 - Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases | Biotech Hunter | Biotech Hunter